Brevan Howard Capital Management »

Keros Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $710k 45k 15.82
2025-06-30 $937k 70k 13.35
2025-03-31 $671k 66k 10.19
2024-12-31 $177k 11k 15.83
2024-09-30 $332k 5.7k 58.07

More positions owned by Brevan Howard Capital Management

Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Pdd Holdings Sponsored Ads Call Option (PDD)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Coinbase Global Com Cl A Call Option (COIN)
Baidu Spon Adr Rep A Call Option (BIDU)
Agnico Call Option (AEM)
Alphabet Cap Stk Cl A Put Option (GOOGL)

View all positions for Brevan Howard Capital Management

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Morgan Stanley
Alkeon Capital Management
Logos Global Management
Geode Capital Management

View all funds holding Keros Therapeutics